All In MedTech

FDA Clearance Tracker · P020050-S001

WAVELIGHT ALLEGRETTO WAVE EXCIMER LASER SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 4, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 4, 2004

Approved

Time to decision

14 days

Received May 21, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P020050-S001
Device name
WAVELIGHT ALLEGRETTO WAVE EXCIMER LASER SYSTEM
Applicant location
Fort Worth, TX
Received
May 21, 2004
Decided
Jun 4, 2004
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Express GMP Supplement
Original approval
P020050

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code LZS

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT WAVELIGHT LASER TECHNOLOGIE AG, PRESSATH, GERMANY.

Source documents

Other decisions for Alcon Laboratories, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.